EpiCept (EPCT) Prices 12 Million Share Offering
Up)
EpiCept Corporation (Nasdaq: EPCT) entered into definitive agreements for the purchase of approximately 12.0 million shares of its common stock at $.80 per share and two-and-one-half-year warrants to purchase up to approximately 4.2 million shares of common stock at an exercise price of $.90 per share exercisable beginning December 19, 2009. The offering is expected to close on or about June 23, 2009, subject to the satisfaction of customary closing conditions. EpiCept will receive approximately $8.9 million in net proceeds from the offering.
Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM) acted as the exclusive placement agent for the offering.
Net proceeds from the offering will be used to meet working capital needs and for general corporate purposes.[SM]
Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM) acted as the exclusive placement agent for the offering.
Net proceeds from the offering will be used to meet working capital needs and for general corporate purposes.[SM]
You May Also Be Interested In
- White Mountains (WTM) Approves Additional 1M Common Buyback
- Acxiom (ACXM) Raises Buyback Program to $150M
- JAKKS Pacific (JAKK) Announces 4M Common Tender at $20/Share
Create E-mail Alert Related Categories
Stock BuybacksRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
